NUCYNTA EXTENDED-RELEASE
Identification of Nucynta Extended-Release
Please sign up for a free trial to see the description of this product.
Examples of the descriptions of OTHER drugs:
Lipitor 10 mg
Apo-Irbesartan 150 mg
Crestor 20 mg
Google image searchProduct monograph
Active ingredient
tapentadol (tapentadol hydrochloride), 250 MG
DIN: 02415615
Dosage form(s): TABLET (EXTENDED-RELEASE)
Route(s) of administration: ORAL
Schedule: Narcotic (CDSA I)
Company: ENDO OPERATIONS LTD.
Date: 24-OCT-2017
ATC:
- N02 — ANALGESICS (ATC, ATC/DDD, )
- N02A — OPIOIDS (ATC, ATC/DDD)
- N02AX — Other opioids (ATC, ATC/DDD)
- N02AX06 — TAPENTADOL (ATC/DDD)
Reference brand drug: Nucynta
